Send feedback

MAPRE2 p.Pro310=

c.930G>A · VCV3905495

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.02%, amr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -8.3GERP -3.2
Overall
CADD0.833PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.02% Admixed American · 12/59,994 alleles
Filtering AF 0.0115% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00898%
Overall 0.00508% 82/1,613,714 alleles · ultra-rare
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.02% 5,000
South Asian 0.011% 9,097
European (non-Finnish) 0.00492% 20,344
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,600
East Asian 0.00223% 44,848

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MAPRE2
Protein
p.Pro310=
Coding
c.930G>A
MANE Select
NM_014268
Type
single nucleotide variant
Location
chr18:35140315 (GRCh38)
Gene constraint
LOEUF 0.494 · pLI 0.99 (gnomAD)
Structure
AlphaFold pLDDT 75.12
Residue 310
the 'dctn1-binding' region; the 'disordered' region
Full MAPRE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mapre2-p-pro310 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown